Marotta Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Marotta Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-80	Closed	-$1.45K	–	113
2022 Q3	$1.45K	Hold	80	–	–	﹤0.01%	110
2022 Q2	$3.84K	Hold	80	–	–	﹤0.01%	110
2022 Q1	$11.3K	Hold	80	–	–	﹤0.01%	113
2021 Q4	$13.7K	Hold	80	–	–	﹤0.01%	112
2021 Q3	$39.8K	Hold	80	–	–	0.01%	101
2021 Q2	$40.6K	Hold	80	–	–	0.01%	100
2021 Q1	$44.4K	Hold	80	–	–	0.01%	93
2020 Q4	$38.2K	Hold	80	–	–	0.01%	85
2020 Q3	$23K	Hold	80	–	–	0.01%	79
2020 Q2	$15.3K	Hold	80	–	–	﹤0.01%	78
2020 Q1	$12.7K	Hold	80	–	–	﹤0.01%	79
2019 Q4	$16.8K	Buy	+80	New	+$10.3K	0.01%	88

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Marotta Asset Management's AMPE Position: Q4 2022 in Review

Marotta Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 80 shares — an estimated $1.45K sold.

Marotta Asset Management first reported a position in AMPE in Q4 2019 and held it in 12 quarters. The position peaked at $44.4K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Marotta Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Marotta Asset Management sold 80 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1.45K.
Marotta Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 12 quarters.
Marotta Asset Management's Ampio Pharmaceuticals Inc. position peaked at $44.4K in Q1 2021.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Marotta Asset Management's 13F filing for Q4 2022, filed 3 Jan 2023.